Jump to Content
Jump to Main Navigation
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Searches
(0)
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Online First
Supplements
NCCN Meeting Highlights
JNCCN In the News
COVID-19
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Harborside
Search
Close
Advanced Search
Help
Volume 9 (2011): Issue 7 (Jul 2011)
in
Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Get eTOC Alerts
Get Ahead of Print Alerts
Citation Alert
NCCN News
Pages: xviii–xxiv
Erratum
Pages: xxxiii
Oncology Research Program
Pages: xxxvi–xxxvii
The Fifth “C” Is Cost: Highlights From ASCO 2011
By:
Harold J. Burstein
Pages: 691
Will Risk Evaluation and Mitigation Strategies Ever Be Accepted?
By:
Edward C. Li
Pages: 696–699
Does Use of the Adjuvant! Model Influence Use of Adjuvant Therapy Through Better Risk Communication?
By:
Jeffrey K. Belkora
,
David W. Hutton
,
Dan H. Moore
and
Laura A. Siminoff
Pages: 707–712
Venous Thromboembolic Disease
By:
Michael B. Streiff
,
Paula L. Bockenstedt
,
Spero R. Cataland
,
Carolyn Chesney
,
Charles Eby
,
John Fanikos
,
Patrick F. Fogarty
,
Shuwei Gao
,
Julio Garcia-Aguilar
,
Samuel Z. Goldhaber
,
Hani Hassoun
,
Paul Hendrie
,
Bjorn Holmstrom
,
Kimberly A. Jones
,
Nicole Kuderer
,
Jason T. Lee
,
Michael M. Millenson
,
Anne T. Neff
,
Thomas L. Ortel
,
Judy L. Smith
,
Gary C. Yee
and
Anaadriana Zakarija
Pages: 714–777
Heparin-Induced Thrombocytopenia in Cancer
By:
Benjamin J. Miriovsky
and
Thomas L. Ortel
Pages: 781–787
Risk Assessment and Prophylaxis for VTE in Cancer Patients
By:
Alok A. Khorana
Pages: 789–797
Risk Stratification for Acute Pulmonary Embolism
By:
Jeffrey A. Kline
and
David W. Miller
Pages: 800–810
Collapse
Expand
Search
Issue
Journal
[3.80.6.131]
3.80.6.131
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
